Latest / The Dales Report | Trade to Black
Why Numinus Made This $6M Strategic Move?
On today's episode of TDR's Trade To Black podcast, we're joined by Payton Nyquvest, Founder and CEO of Numinus Wellness (OTCMKTS: NUMIF), to discuss the latest advancements in psychedelic-assisted therapy. Nyquvest talks about Numinus' recent $6 million funding success, strategic partnerships, and the future of MDMA-assisted therapy for mental health. Key highlights include: 🎙️The significance of the FDA's acceptance of MDMA for therapy and its implications for Numinus and the field at large. 💡The strategic collaboration with Optimi Health Corp, aiming to enhance the development and delivery…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.